Department of Ophthalmology,
University Eye Hospital Heidelberg,
INF 400, 69120 Heidelberg, Germany
Dr. Beutelspacher is one of the leading clinician in the world who works on the retinal transplant and eye related malignancies. He reported for the first time retinal venous vascular occlusion as the primary manifestation of Paroxysmal nocturnal hemoglobinuria (PNH) and suggested that hematopoietic Stem cell may be a cure of the disease. He holds membership of several academic and clinical organizations and has received several scientific awards. He is currently working on the stem cell program to develop the stem cell therapy for retinal differentiation from the embryonic stem cell. His continued findings have been published in several high impact and international clinical journals.